KBC Group’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-520
| Closed | -$104K | – | 1354 |
|
|
2021
Q3 | $104K | Sell |
520
-520
| -50% | -$104K | ﹤0.01% | 1156 |
|
|
2021
Q2 | $266K | Buy |
1,040
+487
| +88% | +$125K | ﹤0.01% | 1137 |
|
|
2021
Q1 | $146K | Hold |
553
| – | – | ﹤0.01% | 1216 |
|
|
2020
Q4 | $1.12M | Hold |
553
| – | – | ﹤0.01% | 1129 |
|
|
2020
Q3 | $136K | Hold |
553
| – | – | ﹤0.01% | 1158 |
|
|
2020
Q2 | $160K | Buy |
553
+330
| +148% | +$95.5K | ﹤0.01% | 1178 |
|
|
2020
Q1 | $46K | Hold |
223
| – | – | ﹤0.01% | 1207 |
|
|
2019
Q4 | $100K | Sell |
223
-119
| -35% | -$53.4K | ﹤0.01% | 1356 |
|
|
2019
Q3 | $105K | Buy |
+342
| New | +$105K | ﹤0.01% | 1330 |
|